DPP4 and diabetes mellitus: DPP4 inhibitors are a novel available antihyperglycemic drug approved for treating type 2 diabetes mellitus (T2DM) in clinical practice, decreasing DPP4 enzyme activity and further increasing the concentration of DPP4 substrates.